The largest database of trusted experimental protocols

6 protocols using optiview dab ihc kit

1

Immunohistochemical Evaluation of PD-L1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four µm sections were cut from FFPE tissue blocks. After deparaffinization, antigen retrieval was performed by CC1 antigen retrieval solution (pH 8.0, Ventana Medical systems, Tuczon, AZ, USA) on the Ventana BenchMark Ultra automated slide stainer. Slides were incubated with the primary PD-L1 antibody (anti-PD-L1, clone 22C3, Merck) at a dilution of 1/100 for 32 min, followed by visualization with the OptiView DAB IHC Kit and OptiView Amplification Kit (Ventana Medical systems). The specimens were then counterstained with haematoxylin and bluing reagent (Ventana Medical systems) and coverslipped.
PD-L1 expression was scored in immune cells in the paracortex and in the sinuses of the lymph node, excluding the germinal centers. Similar to IDO1 scoring, the intensity of PD-L1 staining in the paracortex was evaluated according to a four-tiered grading system (Supplementary Figure 3A): no expression (0), weak expression (1+), moderate expression (2+) or strong expression (3+). PD-L1 expression in the paracortex was dichotomized into an PD-L1-low group (0 and 1+) and an PD-L1-high group (2+ and 3+). In the sinuses, PD-L1 staining was scored as ‘low’ or ‘high’ (Supplementary Figure 3B).
+ Open protocol
+ Expand
2

IHC Protocol for SYP, AR, and DLL3

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC was performed on deparaffinized formalin-fixed paraffin-embedded (FFPE) sections using a Bond III automated immunostainer (Leica Microsystems). Bond Epitope Retrieval Solution 1 (ER1) (at pH 6) or ER2 was used with heat-mediated antigen retrieval. The following antibodies and conditions were used: SYP (SP11, Thermo Fisher Scientific; 1:100 dilution, ER2), AR (F39.4.1, BioGenex; 1:800 dilution with casein, ER1), and DLL3 (SP347, Spring Bioscience). Briefly, SP347 was used at 0.24 μg/ml, followed by a OptiView DAB IHC kit (Ventana) to visualize DLL3 signal. DLL3 positivity was scored at ×4 magnification for any cytoplasmic or membranous staining at any intensity in total tumor cells.
+ Open protocol
+ Expand
3

Immunohistochemical Staining for CD56

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining was performed on 3 µm sections cut from formalin fixed, paraffin embedded tissue blocks using antibodies to CD56 (clone 123C3, 1:50 dilution, DAKO, Carpinteria, CA). Staining was performed on the Ventana Benchmark GX automated system (Ventana Medical Systems, Arizona USA). The protocol of 80 minutes antigen retrieval in CC1 (Ventana), two hours of titrated antibody incubation and detection with the Optiview DAB IHC kit (Ventana) was followed. Controls were included for positive and negative staining. The sections were dehydrated, cleared, mounted with a permanent mounting media and evaluated with a light microscope. Brown cytoplasmic and/or membrane staining was interpreted as positive for the presence of CD56.
+ Open protocol
+ Expand
4

SARS-CoV-2 Antigen Detection in Lung Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SARS-CoV-2 antigen was detected with an anti-SARS-CoV-2-nucleoprotein monoclonal antibody (clone E16C; ThermoFisher, MA, USA), and type II pneumocytes were identified with the anti-Thyroid Transcription Factor-1 (TTF-1) antibody (clone 8G7G3/1, Dako, Denmark). Both were used in combination with a Roche Optiview DAB IHC kit in a Ventana Benchmark Ultra immunostainer (Roche, Basel, Switzerland). Hematoxylin and Eosin (HE) staining was used for general morphology. Slides were assessed in a blind manner.
+ Open protocol
+ Expand
5

Automated BRAF V600E Immunostaining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Automated immunostaining was performed on the Ventana Ultra (Roche). The protocol involved dewaxing with Ezprep solution, followed by heat-induced epitope retrieval with CC1buffer for 64 min and then endogenous peroxidase inhibition. Slides were then incubated with the ready to use BRAF V600E mutation-specific monoclonal antibody, (Ventana, clone VE1 (CE-IVD)) for 16 min at 37 °C. Chromogenic detection was carried out using the OptiView DAB IHC kit (Roche) along with an Optiview amplification kit (Roche). Four minutes Optivew amplification H2O2 and four minutes Optiview amplification multimer incubation times were used. Slides were counterstained with haematoxylin II (Roche) for 4 min followed by bluing reagent (Roche) for 4 min.
Positive staining was seen as the presence of unequivocal cytoplasmic granular staining of any intensity in the tumour cells. Negative staining showed the absence of cytoplasmic staining in the tumour cells.
+ Open protocol
+ Expand
6

SARS-CoV-2 Nucleoprotein Immunohistochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
For viral antigen staining, a Roche Optiview DAB IHC kit, in combination with an anti-SARS-CoV-2-nucleoprotein (clone E16C; ThermoFisher), was used in a Ventana Benchmark Ultra immunostainer (Roche, Basel Switzerland), as previously described [7 (link)]. In brief, antigen retrieval took place with cell conditioning 1 (CC1, Ventana Medical Systems) (pH 8.5) for 24 min at 100 °C, 1/5.000 diluted. Thereafter, incubation took place with the primary antibody for 48 min at 36 °C, followed by standard Optiview detection/visualization with DAB and Copper.
After immunohistochemical staining, the sections were dehydrated and mounted with TissueTek® coverslipping film (Sakura Finetek Europe B.V., The Netherlands). Hematoxylin-eosin (HE) staining was used for general morphology. Cells were counted in a blind manner. As a positive control, a lung section of a deceased COVID-patient was included (Figure S1).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!